Complete Genomics Workshop at ASHG 2015 to Feature Game-Changing Sequencing Innovations and Their Role in Clinical Research

Sep 21, 2015, 10:00 ET from Complete Genomics, Inc.

MOUNTAIN VIEW, Calif., Sept. 21, 2015 /PRNewswire/ -- Complete Genomics, Inc., a leader in human genomic sequencing, will host a luncheon workshop, Advances in Genome Sequencing, for attendees at the upcoming 65th Annual Meeting of the American Society of Human Genetics (ASHG) in Baltimore, Maryland. Workshop attendees will have the opportunity to hear leading scientists discuss their research and offer insights into future directions and innovations in genome sequencing. The high-performance Revolocity system, a supersequencer for large-scale, high-quality whole genome and whole exome sequencing, will be highlighted.

The workshop will take place on Wednesday, October 7, from 1:00 to 2:30 pm at the Key Ballroom of the Hilton Baltimore Hotel (Baltimore, MD). The program will include:

Genome and Exome Sequencing on Complete Genomics' Revolocity System: A Validation Study
Joris Veltman, PhD
Professor of Translational Genomics, Radboud University Medical Centre and Maastricht University Medical Centre, Nijmegen and Maastricht, the Netherlands

Whole Genome Sequencing Is a Clinically Effective Strategy for Inherited Cardiac Disorders
Paul A. James, MbChB, DPhil (Oxf), FRACP
Consultant, Familial Cancer Centre, Peter MacCallum Cancer Centre; Head, Adult Genetics, Royal Melbourne Hospital; Clinical Associate Professor, Department of Medicine, Monash University, Melbourne, Australia

Revolocity Performance: Supersequencing for WGS and WES
Chitra Kotwaliwale, PhD
Senior Product Manager, Complete Genomics, Mountain View, California

ASHG attendees can register for the Complete Genomics workshop here. Space is limited and reservations will be accepted on a first-come, first-served basis. More information is available at the Complete Genomics website.

About Complete Genomics
Complete Genomics is a leader in whole human genome sequencing based in Mountain View, California. Using its proprietary sequencing instruments, chemistry, and software, the company has sequenced more than 20,000 whole human genomes. The company's mission is to improve human health by providing researchers and clinicians with the core technology and commercial systems to understand, prevent, diagnose, and treat diseases and conditions. Additional information can be found at

Ed Stevens


SOURCE Complete Genomics, Inc.